The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent thei ...

For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation ...

Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, accordi ...

COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disabilit ...

Multimorbidity is strongly associated with accelerated kidney function decline in older age, according to a study pu ...

The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research l ...